Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-02-26 @ 12:20 AM
Study NCT ID:
NCT02924402
Status:
COMPLETED
Last Update Posted:
2024-11-13
First Post:
2016-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
Sponsor:
Xencor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-14
First Submit QC Date:
None
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-12
Last Update Post Date:
2024-11-13
Last Update Post Date Type:
ACTUAL